Finoriq research workspace
Gelteq Ltd (GELS) Institutional Holdings & 13F Ownership
Gelteq Ltd offers edible gels for prescription drugs, nutraceuticals, pet care, and other. Review GELS institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
- Company
- Gelteq Ltd (GELS)
- Ticker
- GELS
- Market Cap
- $6.2M
- Latest Price
- $0.5776
- Industry
- Biotech & Pharma
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.